Patent intelligence · US
US 11045504
Compositions and methods for treatment of cancer using bacteria
Compositions and methods for treatment of cancer using bacteria
Patent details — US 11045504
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 29, 2021
- Expiration
- Jun 24, 2041
- Applicant
- Decoy Biosystems, Inc.
- Claims
- 10
- CPC classes
- A61K, A61K2039/521, A61K2039/522, A61K2039/523
Quick answer
US 11045504 (Compositions and methods for treatment of cancer using bacteria) is held by Decoy Biosystems, Inc.. Status: granted. Granted Jun 29, 2021. Expires Jun 24, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Decoy Biosystems, Inc.
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K2039/521, A61K2039/522, A61K2039/523, A61K2039/585, A61K31/11
More from Decoy Biosystems, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12226474
Methods and compositions for treating infections
granted -
US 11147844
Methods of treatment of infections using bacteria
granted -
US 10195259
Compositions and methods for treatment of cancer using bacteria
granted -
US 10052371
Compositions and methods for treatment of cancer using bacteria
granted -
US 9265804
Compositions and methods for treatment of cancer using bacteria
granted
Frequently asked questions
What is US patent 11045504?
US 11045504 (Compositions and methods for treatment of cancer using bacteria) is held by Decoy Biosystems, Inc.. Status: granted. Granted Jun 29, 2021. Expires Jun 24, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11045504?
Decoy Biosystems, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 6 pharmaceutical patents for this assignee.
When does US 11045504 expire?
Our index shows an expiration date of Jun 24, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.